These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17089915)

  • 1. Immunological profiles of patients with chronic myeloid leukaemia. I. State before the start of treatment.
    Humlová Z; Klamová H; Janatková I; Sandová P; Sterzl I; Sobotková E; Hamsíková E; Haskovec C; Písacka M; Cetkovský P; Michalová K; Faber E; Hermanová Z; Ordeltová M; Roubalová K; Roth Z; Vonka V
    Folia Biol (Praha); 2006; 52(3):47-58. PubMed ID: 17089915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment.
    Humlová Z; Klamová H; Janatková I; Malíčková K; Králíková P; Sterzl I; Roth Z; Hamšíková E; Vonka V
    Clin Dev Immunol; 2010; 2010():137320. PubMed ID: 21197073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
    Eisendle K; Lang A; Eibl B; Nachbaur D; Glassl H; Fiegl M; Thaler J; Gastl G
    Br J Haematol; 2003 Jan; 120(1):63-73. PubMed ID: 12492578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
    Hus I; Tabarkiewicz J; Lewandowska M; Wasiak M; Wdowiak P; Kusz M; Legieć M; Dmoszyńska A; Roliński J
    Folia Histochem Cytobiol; 2011; 49(1):153-60. PubMed ID: 21526503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia.
    Chen X; Regn S; Raffegerst S; Kolb HJ; Roskrow M
    Br J Haematol; 2000 Nov; 111(2):596-607. PubMed ID: 11122108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension: An immune related disorder?
    Sereti E; Stamatelopoulos KS; Zakopoulos NA; Evangelopoulou A; Mavragani CP; Evangelopoulos ME
    Clin Immunol; 2020 Mar; 212():108247. PubMed ID: 31401215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice.
    Chen CI; Koschmieder S; Kerstiens L; Schemionek M; Altvater B; Pscherer S; Gerss J; Maecker HT; Berdel WE; Juergens H; Lee PP; Rossig C
    Leukemia; 2012 Mar; 26(3):465-74. PubMed ID: 21904381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Ptackova P; Petrackova M; Hindos M; Duskova M; Hamsikova E; Klamova H; Pecherkova P; Humlova Z; Vonka V
    Acta Haematol; 2017; 137(3):148-157. PubMed ID: 28376476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
    Westermann J; Schlimper C; Richter G; Mohm J; Dörken B; Pezzutto A
    Br J Haematol; 2004 Apr; 125(2):213-6. PubMed ID: 15059144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia as an immunological target.
    Lim SH; Coleman S
    Am J Hematol; 1997 Jan; 54(1):61-7. PubMed ID: 8980262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiling as a prognostic markers in chronic myeloid leukemia patients.
    Singer MK; Assem M; Abdel Ghaffar AB; Morcos NY
    Egypt J Immunol; 2011; 18(2):37-46. PubMed ID: 23082469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia.
    Coleman S; Throp D; Fisher J; Bailey-Wood R; Lim SH
    Leukemia; 1997 Dec; 11(12):2055-9. PubMed ID: 9447820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission.
    Pagani IS; Dang P; Saunders VA; Grose R; Shanmuganathan N; Kok CH; Carne L; Rwodzi Z; Watts S; McLean J; Braley J; Altamura H; Yeung DT; Branford S; Yong ASM; White DL; Hughes TP; Ross DM
    Leukemia; 2020 Apr; 34(4):1052-1061. PubMed ID: 31768016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I and type II T cell profiles in chronic myelogenous leukemia.
    Tsuda H; Yamasaki H
    Acta Haematol; 2000; 103(2):96-101. PubMed ID: 10838453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.
    Austin GM; Knight K; Bell J; Carter A; Heartin E; Watson D; Foroni L; Christmas SE; Polydoros F; Clark RE
    Br J Haematol; 2019 May; 185(4):791-793. PubMed ID: 30408160
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal immunological response to Mycobacterium tuberculosis antigens in a patient with chronic myelocytic leukemia and active tuberculosis.
    Vilá LM; Ríos-Olivares E; Ríos Z; Meléndez M; García M; Pichardo B
    P R Health Sci J; 1998 Dec; 17(4):345-52. PubMed ID: 10028542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors.
    Rodrigues-Santos P; López-Sejas N; Almeida JS; Ruzičková L; Couceiro P; Alves V; Campos C; Alonso C; Tarazona R; Freitas-Tavares P; Solana R; Santos-Rosa M
    Front Immunol; 2018; 9():2587. PubMed ID: 30487792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological changes after a single bout of moderate-intensity exercise in a hot environment.
    Romeo J; Jiménez-Pavón D; Cervantes-Borunda M; Wärnberg J; Gómez-Martínez S; Castillo MJ; Marcos A
    J Physiol Biochem; 2008 Sep; 64(3):197-204. PubMed ID: 19244933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of autologous lymphocytes of patients with chronic myelogenous leukemia in the chronic phase with cytokines and CD3 monoclonal antibody results in bcr/abl- blood leukocyte cultures as determined by reverse transcriptase-polymerase chain reaction.
    Krackhardt A; Maurer J; Thiel E; Notter M
    Exp Hematol; 1998 Dec; 26(13):1265-70. PubMed ID: 9845383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.